Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity-Reference-Cited by-同舟云学术

Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity

Published:2015-07-28 Issue:7 Volume:10 Page:e0134493
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Zhang Tianwei,Zhang Lin,Fan Shuqiong,Zhang Meizhuo,Fu Haihua,Liu Yuanjie,Yin Xiaolu,Chen Hao,Xie Liang,Zhang Jingchuan,Gavine Paul R.,Gu Yi,Ni Xingzhi,Su Xinying

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference60 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012;J Ferlay;Int J Cancer,2015

2. Advanced gastric cancer—slow but steady progress;DG Power;Cancer Treat Rev,2010

3. New targeted therapies for gastric cancer;Y Asaoka;Expert Opin Investig Drugs,2011

4. HER2 therapies and gastric cancer: a step forward;RA de Mello;World J Gastroenterol,2013

5. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial;YJ Bang;Lancet,2010

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomics, Molecular Pathology, and Pathology of Esophageal and Gastric Cancer;Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e;2024-01-23

2. Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges;BMC Cancer;2023-12-07

3. Generation, evolution, interfering factors, applications, and challenges of patient-derived xenograft models in immunodeficient mice;Cancer Cell International;2023-06-21

4. Patient-Derived Xenograft: A More Standard “Avatar” Model in Preclinical Studies of Gastric Cancer;Frontiers in Oncology;2022-05-19

5. Patient-derived xenograft (PDX) models, applications and challenges in cancer research;Journal of Translational Medicine;2022-05-10